McDermott Will & Emery Advises Acticor Biotech


Emmanuelle Trombe, Anthony Paronneau, Kamal Naffi and Mathilde Peschard of McDermott’s Paris office represented Acticor Biotech, a biotechnology company dedicated to the development of an emergency treatment for strokes, in securing a €590,000 capital increase from investors in the crowdfunding platform Anaxago and Business Angels. The company will use the funds for product development. Read the full article